515 related articles for article (PubMed ID: 28391781)
1. Multiple Sclerosis: Epidemiologic, Clinical, and Therapeutic Aspects.
Vidal-Jordana A; Montalban X
Neuroimaging Clin N Am; 2017 May; 27(2):195-204. PubMed ID: 28391781
[TBL] [Abstract][Full Text] [Related]
2. [Clinical, radiographic, prognostic and therapeutic aspects of demelinating disease with tumefactive demyelinating lesions].
Launay M; Lebrun C; Giordana E; Chanalet S; Thomas P
Rev Neurol (Paris); 2011 Jan; 167(1):14-22. PubMed ID: 20739040
[TBL] [Abstract][Full Text] [Related]
3. Drugs for multiple sclerosis.
Med Lett Drugs Ther; 2021 Mar; 63(1620):42-48. PubMed ID: 33976089
[No Abstract] [Full Text] [Related]
4. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of relapsing-remitting multiple sclerosis.
Tanasescu R; Ionete C; Chou IJ; Constantinescu CS
Biomed J; 2014; 37(2):41-9. PubMed ID: 24732658
[TBL] [Abstract][Full Text] [Related]
6. Evolving concepts in the treatment of relapsing multiple sclerosis.
Comi G; Radaelli M; Soelberg Sørensen P
Lancet; 2017 Apr; 389(10076):1347-1356. PubMed ID: 27889192
[TBL] [Abstract][Full Text] [Related]
7. New Advances in Disease-Modifying Therapies for Relapsing and Progressive Forms of Multiple Sclerosis.
Vidal-Jordana A
Neurol Clin; 2018 Feb; 36(1):173-183. PubMed ID: 29157398
[TBL] [Abstract][Full Text] [Related]
8. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Wynn D; Kaufman M; Montalban X; Vollmer T; Simon J; Elkins J; O'Neill G; Neyer L; Sheridan J; Wang C; Fong A; Rose JW;
Lancet Neurol; 2010 Apr; 9(4):381-90. PubMed ID: 20163990
[TBL] [Abstract][Full Text] [Related]
9. Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.
Ouallet JC
Rev Neurol (Paris); 2020 Jun; 176(6):500-504. PubMed ID: 32278541
[TBL] [Abstract][Full Text] [Related]
10. Secondary progressive multiple sclerosis: current knowledge and future challenges.
Rovaris M; Confavreux C; Furlan R; Kappos L; Comi G; Filippi M
Lancet Neurol; 2006 Apr; 5(4):343-54. PubMed ID: 16545751
[TBL] [Abstract][Full Text] [Related]
11. New Drug For Multiple Sclerosis.
Aschenbrenner DS
Am J Nurs; 2017 Jul; 117(7):22. PubMed ID: 28644283
[No Abstract] [Full Text] [Related]
12. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
Sørensen PS
J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763
[TBL] [Abstract][Full Text] [Related]
13. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of multiple sclerosis].
Simó M
Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
Nikfar S; Rahimi R; Abdollahi M
Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification and mitigation multiple sclerosis.
Ontaneda D; Cohn S; Fox R
Mult Scler Relat Disord; 2014 Sep; 3(5):639-49. PubMed ID: 25221744
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic options for multiple sclerosis.
Curtin F; Hartung HP
Expert Rev Clin Pharmacol; 2014 Jan; 7(1):91-104. PubMed ID: 24325127
[TBL] [Abstract][Full Text] [Related]
18. Switching therapies in MS: what are the options?
Markowitz CE
J Clin Psychiatry; 2015 Feb; 76(2):e6. PubMed ID: 25742221
[No Abstract] [Full Text] [Related]
19. Current disease-modifying therapies in multiple sclerosis.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
[TBL] [Abstract][Full Text] [Related]
20. [Family planning in multiple sclerosis: conception, pregnancy, breastfeeding].
Rózsa C
Ideggyogy Sz; 2020 May; 73(05-06):161-169. PubMed ID: 32579305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
